Bavarian Nordic to test its Covid-19 booster against Pfizer/BioNTech shot in pivotal study

As Bavarian Nordic has made strides recently to beef up its smallpox vaccine manufacturing in the wake of new monkeypox cases, the company is also getting ready to evaluate its Covid-19 booster in a pivotal study. And it’s going after one of the heavyweights.